by Jordana Choucair | Feb 1, 2022 | Life Sciences
The FDA granted Moderna’s COVID-19 vaccine full approval for use in people aged 18 and older. The vaccine, named Spikevax, is the second COVID-19 vaccine to receive full approval from the FDA, behind Pfizer’s Comirnaty vaccine. There’s no difference between the...
by Jordana Choucair | Feb 1, 2022 | Providers
Kaufman Hall’s latest monthly report found that hospitals performed better in 2021, although the industry is “still performing well below 2019” in regard to margins and volumes. According to the report, hospitals’ median change in operating margin for the full year of...
by Jordana Choucair | Feb 1, 2022 | Transition to Value
A new Lancet Commission on the Value of Death released a report calling for society to “rethink” how it approaches death. According to the authors, “How people die has changed dramatically over the past 60 years, from a family event with occasional medical...
by Jordana Choucair | Jan 31, 2022 | D.C. News
Senators Patty Murray and Richard Burr are seeking a speedy path forward for their pandemic preparedness bill. Advocates close to the discussions say that it could be tied to other proposals on biomedical research that are in the mix, or that parts of the plan could...
by Jordana Choucair | Jan 31, 2022 | Life Sciences
About 150 drugmakers raised their list prices by an average of 6.6 percent for 866 medicines in the United States in the first few weeks of 2022. The analysis from Rx Savings Solutions shows that the average price hike was higher than the 4.5 percent increase over the...
by Jordana Choucair | Jan 31, 2022 | Payers
Last week, AHIP submitted comments reflecting the group’s concerns with provisions in the HHS Notice of Benefit and Payment Parameters for 2023. AHIP warned that proposed requirement for insurers to offer standardized plan options on the exchanges would “stifle...
Recent Comments